A two-strain vaccine will better protect against fast-moving virus, says an FDA panel.
Troubled by waning immune protection against the COVID virus, this fall’s vaccine booster should be a redesigned two-strain version, according to a recommendation by the FDA’s panel of experts on Tuesday.
Public health experts are braced for a larger surge in cases this fall and winter, as people head indoors. Between 95,000 and 211,000 people could die of COVID between March 2022 and March 2023, Lessler said. Doses of modified vaccine could cost the federal government about $5 billion to $12 billion, one senior federal official told The New York Times.
Offit expressed concern about the speed of the shift, based on relatively small clinical studies. “I think as a new product it should be handled as a new product,” he said. “I think we need a higher standard than what we’ve been given. I think it’s uncomfortably scant.”
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA advisers recommend updating COVID booster shots for fallGovernment advisers are recommending that some U.S. adults get a modified COVID-19 booster shot this fall — one that better matches more recent virus variants
Read more »
FDA advisers recommend updating COVID booster shots for fallSome U.S. adults are a step closer to getting updated COVID-19 boosters this fall, as government advisers voted Tuesday that it’s time to tweak shots to better match the most recent virus variants.
Read more »
FDA advisers recommend updating COVID booster shots to match newer variantsAdvisers to the U.S. government are recommending that COVID-19 booster shots used this fall be modified to better match more recent variants of the coronavirus.
Read more »
FDA may move toward updating COVID-19 vaccines for fall booster shotsA panel of independent experts advising the Food and Drug Administration is set to recommend Tuesday whether to update existing COVID-19 vaccines to target a newer version of the coronavirus in a booster shot that Americans could get in the fall.
Read more »
U.S. FDA will decide on redesigned COVID vaccines by early JulyU.S. regulators plan to decide by early July whether to change the design of COVID-19 vaccines this fall in order to combat more recent variants of the coronavirus, with hopes of launching a booster campaign by October, a top Food and Drug Administration official said on Tuesday.
Read more »
FDA advisers recommend updating COVID booster shots for fallGovernment advisers debated Tuesday if Americans should get a modified COVID-19 booster shot this fall, and exactly how best to update it to fight a virus that surely will change even more by then.
Read more »